arrow
返回
A

Arshad M. Khanani

Sierra Eye Associates

33H指数
161论文数
4.8K被引数
收录论文 43
发表时间
Defining a standards framework for ophthalmology real-world data methodologies through an expert-led Delphi consensus通过专家引导的德尔菲共识,为眼科真实世界数据方法学定义一个标准框架
errEye
IF3.2
err2026-04-02
err0
errOAAI
errPierre-Henry Gabrielle; Francesco Bandello; Aude Couturier; Christiana Dinah; Amanda Downey; Alessandro Invernizzi; Arshad M. Khanani; Jorge C. P. Rocha; Insaf Saffar; Javier Zarranz-Ventura; Rishi P. Singh
err分享
err收藏
Reduction in Pigment Epithelial Detachment Thickness with Faricimab versus Aflibercept 2 mg during Head-to-Head Dosing in TENAYA/LUCERNE与阿柏西普2 mg相比,在TENAYA/LUCERNE头对头给药期间,Faricimab对色素上皮脱离厚度的降低
err2026-03-10
err0
errOAAI
errJennifer I. Lim; Aude Ambresin; Robert L. Avery; Voraporn Chaikitmongkol; Nicole Eter; Fumi Gomi; Arshad M. Khanani; Nikolas J.S. London; Emma Harrell; Philippe Margaron; Shriji Patel; Audrey Souverain; Ming Yang; Timothy Y.Y. Lai
err分享
err收藏
A novel modifier gene therapy to treat Stargardt disease: Phase 1 GARDian1 Trial Insights
errEye
IF3.2
err2026-01-10
err0
errOAAI
errArshad M. Khanani; Lejla Vajzovic; Benjamin Bakall; Venkata Ramana Murthy Chavali; Huma Qamar
err分享
err收藏
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 2-year efficacy and safety results from the GATHER2 phase 3 trial阿瓦辛卡帕德·贝戈尔(Avacincaptad pegol)用于年龄相关性黄斑变性继发的地理性萎缩:GATHER2三期试验2年的疗效和安全性结果
err2025-12-15
err0
errOAAI
errArshad M. Khanani; Carl J. Danzig; Jeffrey S. Heier; Glenn J. Jaffe; Peter K. Kaiser; David R. Lally; Sunil S. Patel; Lejla Vajzovic; Christina Y. Weng; Hersh Patel; Julie Clark; Dhaval Desai; Don Luo; Erin Henry; Frank G. Holz
err分享
err收藏
REPLY回复
err2025-07-26
err0
PREAI
errDavid M. Brown; Glenn J. Jaffe; Charles C. Wykoff; Eser Adiguzel; Jeffrey S. Heier; Arshad M. Khanani
err分享
err收藏
Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration针对老年性黄斑变性继发性地理萎缩的抗高温要求A1 (HtrA1) Fab Galegenimab (FHTR2163)的二期研究
err2025-07-01
err0
PREAI
errEichenbaum, DA; Holekamp, N; Khanani, AM; Pieramici, D; Hershberger, V; Sheth, V; Brunstein, F; Ma, L; Zou, YX; Indjeian, VB; Dere, R; Maia, M; Hsu, JC; Gao, SS; Yaspan, B; Willis, JR; Wiley, H; Lai, PL; Chen, H
err分享
err收藏
Phase I Study of the Anti-interleukin 33 Fragment Antigen-Binding Region RO7303359 in Geographic Atrophy Secondary to Age-Related Macular DegenerationI期研究:抗白介素33片段抗原结合区RO7303359在年龄相关性黄斑变性继发性地理萎缩中的应用
err2025-04-20
err0
errOAAI
errJoel A. Pearlman; Veeral S. Sheth; Arshad M. Khanani; Vahan B. Indjeian; Flavia Brunstein; Denison Kuruvilla; Mauricio Maia; Randall Dere; Ling Ma; Hao Chen; Seema Datta; Jeffrey R. Willis; Henry E. Wiley
err分享
err收藏
Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein OcclusionFaricimab 治疗并延长给药方案用于视网膜静脉阻塞引起的黄斑水肿
err2025-03-17
err0
errOAAI
errCarl J. Danzig; Christiana Dinah; Faruque Ghanchi; Lars-Olof Hattenbach; Arshad M. Khanani; Timothy Y.Y. Lai; Masahiko Shimura; Francis Abreu; Pablo Arrisi; Ying Liu; Liliana P. Paris; Anne-Cecile Retiere; Jeffrey R. Willis; Patricio G. Schlottmann
err分享
err收藏
err分享
err收藏
Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies
err2024-12-02
err0
errOAAI
errCalton, Melissa A.; Croze, Roxanne H.; Burns, Christian; Beliakoff, Ghezal; Vazin, Tandis; Szymanski, Paul; Schmitt, Christopher; Klein, Austin; Leong, Meredith; Quezada, Melissa; Holt, Jenny; Bolender, Gabe; Barglow, Katherine; Khoday, Devi; Mason, Thomas; Delaria, Katherine; Hassanipour, Mohammad; Kotterman, Melissa; Khanani, Arshad M.; Schaffer, David; Francis, Peter; Kirn, David
err分享
err收藏
Resolution of Angiographic Macular Leakage with Faricimab versus Aflibercept in Patients with Diabetic Macular Edema in YOSEMITE/RHINEYOSEMITE/RHINE研究中,Faricimab与Aflibercept治疗糖尿病黄斑水肿患者的血管造影黄斑渗漏的消退比较
err2024-11-22
err0
errOAAI
errRoger A. Goldberg; Florie A. Mar; Karl Csaky; Manuel Amador; Arshad M. Khanani; Kara Gibson; Anton M. Kolomeyer; Dawn A. Sim; Toshinori Murata; Tracey Wang; Patricia Udaondo; Audrey Souverain; Yevgeniy (Eugene) Shildkrot; Stela Vujosevic; Eric Nudleman; Sobha Sivaprasad
err分享
err收藏
Approved treatments for neovascular age-related macular degeneration: current safety and future directions
err2024-08-05
err2
PREAI
errKhan, Hannah; Aziz, Aamir A.; Khanani, Zoha; Khan, Huma; Mojumder, Ohidul; Gahn, Greggory M.; Khanani, Arshad M.
err分享
err收藏
Two-Year Results from the Phase 3 Neovascular Age- Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2Faricimab治疗和延长给药2年的3期新生血管性年龄相关性黄斑变性试验的两年结果
err2024-08-01
err24
errOAAI
errKhanani, Arshad M.; Kotecha, Aachal; Chang, Andrew; Chen, Shih-Jen; Chen, Youxin; Guymer, Robyn; Heier, Jeffrey S.; Holz, Frank G.; Iida, Tomohiro; Ives, Jane A.; Lim, Jennifer I.; Lin, Hugh; Michels, Stephan; Ruiz, Carlos Quezada; Schmidt-Erfurth, Ursula; Silverman, David; Singh, Rishi; Swaminathan, Balakumar; Willis, Jeffrey R.; Tadayoni, Ramin
err分享
err收藏
Efficacy fi cacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion 24-Week Results from the BALATON and COMINO Trials
err2024-08-01
err8
errOAAI
errTadayoni, Ramin; Paris, Liliana P.; Danzig, Carl J.; Abreu, Francis; Khanani, Arshad M.; Brittain, Christopher; Lai, Timothy Y. Y.; Haskova, Zdenka; Sakamoto, Taiji; Kotecha, Aachal; Schlottmann, Patricio G.; Liu, Ying; Seres, Andras; Retiere, Anne-Cecile; Willis, Jeffrey R.; Yoon, Young Hee
err分享
err收藏
Bispecific VEGF-A and Angiopoietin-2 Antagonist RO-101 Preclinical Efficacy in Model of Neovascular Eye Disease
err2024-07-01
err0
errOAAI
errXu, Li; Prentice, Jessi R.; Velez-Montoya, Raul; Sinha, Alina; Barakat, Mark R.; Gupta, Ashwin; Lowenthal, Robert; Khanani, Arshad M.; Kaiser, Peter K.; Heier, Jeffrey S.; Jones, Anthony; Morgenstern, Joshua L.; Caldwell, Anne Strong; Mueller, Niklaus; Quiroz-Mercado, Hugo; Huvard, Michael; Olson, Jeffrey L.; Bhatt, Ramesh; Bhandan, Ramanath
err分享
err收藏
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study通过视网膜下递送RGX-314对新生血管性年龄相关性黄斑变性进行基因治疗: 1/2a期剂量递增研究
errLANCET
IF88.5
err2024-04-01
err15
PREAI
errCampochiaro, Peter A.; Avery, Robert; Brown, David M.; Heier, Jeffrey S.; Ho, Allen C.; Huddleston, Stephen M.; Jaffe, Glenn J.; Khanani, Arshad M.; Pakola, Stephen; Pieramici, Dante J.; Wykoff, Charles C.; Van Everen, Sherri
err分享
err收藏